Caffeine-induced increases in the brain and plasma concentrations of neuroactive steroids in the rat

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 1, 2000, Pages 39-45

  Concas, Alessandra ^a   Porcu, Patrizia ^b   Sogliano, Cristiana ^b   Serra, Mariangela ^b   Purdy, Robert H ^a   Biggio, Giovanni ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Allopregnanolone; Brain; Caffeine; Corticosterone; HPA axis; Neuroactive steroids; Plasma; Rat

Indexed keywords

3ALPHA HYDROXY 5ALPHA PREGNAN 20 ONE; CAFFEINE; CORTICOSTERONE; NEUROSTEROID; PRASTERONE; PREGNENOLONE; PROGESTERONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BEHAVIOR; BEVERAGE; BRAIN CORTEX; CONTROLLED STUDY; DOSE RESPONSE; HORMONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NEUROCHEMISTRY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SUBSTANCE ABUSE;

ANIMALS; CAFFEINE; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; PREGNANOLONE; PREGNENOLONE; PROGESTERONE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0034105173     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00237-9     Document Type: Article

References (44)

1. Anand-Srivastava M.B., Cantin M., Gutkoska J. Adenosine regulates the release of adrenocorticotropic hormone (ACTH) from cultured anterior pituitary cells. Mol. Cell. Biochem. 89:1989;21-28.
2. Barbaccia M.L., Roscetti G., Bolacchi F., Concas A., Mostallino M.C., Purdy R.H., Biggio G. Stress-induced increase in brain neuroactive steroids. antagonism by abecarnil Pharmacol. Biochem. Behav. 54:1996;205-210.
3. A receptor function after acute stress. Neuroendocrinology. 63:1996;166-172.
4. Barbaccia M.L., Roscetti G., Trabucchi M., Purdy R.H., Mostallino M.C., Concas A., Biggio G. The effects of inhibitors of GABAergic transmission and stress on brain and plasma allopregnanolone concentrations. Br. J. Pharmacol. 120:1997;1582-1588.
5. Belelli D., Bolger M.B., Gee K.W. Anticonvulsant profile of the progesterone metabolite 5a-pregnan-3α-ol-20-one. Eur. J. Pharmacol. 166:1989;325-329.
6. Bhattacharya S.K., Satyan K.S., Chakrabarti A. Anxiogenic action of caffeine. an experimental study in rats J. Psychopharmacol. 11:1997;219-224.
7. A receptor function. Pharmacol. Biochem. Behav. 45:1993;423-428.
8. Boutroy M.J., Vert P., Royer R.J., Monin P., Royer-Morrot M.J. Caffeine, a metabolite of theophylline during the treatment of apnea in the premature infant. J. Pediatrics. 94:1979;996-997.
9. Britton D.R., Indyk E. Central effects of corticotropin releasing factor (CRF). evidence for similar interactions with environmental novelty and with caffeine Psychopharmacology. 101:1990;366-370.
10. 1 receptors. J. Pharmacol. Exp. Ther. 273:1995;637-642.
11. Cheney D.L., Uzunov D., Costa E., Guidotti A. Gas chromatographic-mass fragmentographic quantitation of 3α-hydroxy-5α-pregnan-20-one (allopregnanolone) and its precursors in blood and brain of adrenalectomized and castrated rats. J. Neurosci. 15:1995;4641-4650.
12. Chu N.S. Caffeine- and aminophylline-induced seizures. Epilepsia. 22:1981;85-94.
13. 35S]TBPS binding in the brain of rats exposed to isoniazid, pentylenetetrazol or stress. Br. J. Pharmacol. 118:1996;839-846.
14. Concas A., Mostallino M.C., Porcu P., Follesa P., Barbaccia M.L., Trabucchi M., Purdy R.H., Biggio G. Role of brain allopregnanolone in the plasticity of γ-aminobutyric acid type A receptor in rat brain during pregnancy and after delivery. Proc. Natl. Acad. Sci. USA. 95:1998;13284-13289.
15. Corda M.G., Blaker W.D., Mendelson W.B., Guidotti A., Costa E. β-Carbolines enhance shock-induced suppression of drinking in rats. Proc. Natl. Acad. Sci. USA. 80:1983;2072-2076.
16. Corpéchot C., Collins B.E., Carey M.P., Tsouros A., Robel P., Fry J.P. Brain neurosteroids during the mouse oestrous cycle. Brain Res. 766:1997;276-280.
17. Daly J.W., Bruns R.F., Snyder S.N. Adenosine receptors in the central nervous system. relationship to the central action of methylxanthines Life Sci. 28:1981;2083-2097.
18. Dazzi L., Sanna A., Cagetti E., Concas A., Biggio G. Inhibition by the neurosteroid allopregnanolone of basal and stress-induced acetylcholine release in the brain of freely moving rats. Brain Res. 710:1996;275-280.
19. Dorow R., Horowski R., Paschelke G., Amin M., Braestrup C. Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptor. Lancet. 41:1983;98-99.
20. File S., Baldwin H.A., Johnston A.L., Wilks L.J. Behavioral effects of acute and chronic administration of caffeine in the rat. Pharmacol. Biochem. Behav. 30:1988;809-815.
21. Ghoneim M.M., Mewaldt S.P., Hinrichs J.V. Dose-response analysis of the behavioral effects of diazepam. II. Psychomotor performance, cognition and mood Psychopharmacology. 82:1984;296-300.
22. Goldstein A. Wakefulness caused by caffeine. Naunyn-Schmiedebergs Arch. Pharmacol. Exp. Pathol. 248:1964;269-278.
23. Jensen L.H., Stephens D.N., Sarter M., Petersen E.N. Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes. Brain Res. Bull. 19:1987;359-364.
24. A receptor function. Trends Pharmacol. Sci. 16:1995;295-303.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-276.
26. A receptor. Mechanism of action and physiological significance Prog. Neurobiol. 38:1992;379-395.
27. Marangos P.J., Martino A.M., Paul S.M., Skolnick P. The benzodiazepines and inosine antagonize caffeine-induced seizures. Psychopharmacology. 72:1981;269-273.
28. Mendelson W.B., Martin J.V., Perlis M., Wagner R., Majewska M.D., Paul S.M. Sleep induction by adrenal steroids in the rat. Psychopharmacology. 93:1987;226-229.
29. Motzo C., Porceddu M.L., Maira G., Flore G., Concas A., Dazzi L., Biggio G. Inhibition of basal and stress-induced dopamine release in the cerebral cortex and nucleus accumbens of freely moving rats by the neurosteroid allopregnanolone. J. Psychopharmacol. 10:1996;266-272.
30. Nehlig A., Daval J.-L., Debry G. Caffeine and the central nervous system. Mechanisms of action, biochemical, metabolic and psychostimulant effects. Brain Res. Rev. 17:1992;139-170.
31. Nicholson S.A. Stimulatory effect of caffeine on the hypothalamo-pituitary-adrenocortical axis in the rat. J. Endocrinol. 122:1989;535-543.
32. Ninan P.T., Insel T.M., Cohen R.M., Cook J.M., Skolnick P., Paul S.M. Benzodiazepine receptor-mediated experimental "anxiety" in primates. Science. 218:1982;1332-1334.
33. Okada M., Kiryu K., Kawata Y., Mizuno K., Wada K., Tasaki H., Kaneko S. Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis. Eur. J. Pharmacol. 321:1997;181-188.
34. Patchev V.K., Hassan A.H.S., Holsboer F., Almeida O.F.X. The neurosteroid tetrahydroprogesterone attenuates the endocrine response to stress and exerts glucocorticoid-like effects on vasopressin gene transcription in the rat hypothalamus. Neuropsychopharmacology. 15:1996;533-540.
35. Paul S.M., Purdy R.H. Neuroactive steroids. FASEB J. 6:1992;2311-2322.
36. Purdy R.H., Morrow A.L., Moore P.H. Jr., Paul S.M. Stress-induced elevations of γ-aminobutyric acid type A receptor-active steroids in the rat brain. Proc. Natl. Acad. Sci. USA. 88:1991;4553-4557.
37. Roache J.D., Griffiths R.R. Interactions of diazepam and caffeine. behavioral and subjective dose effects in humans Pharmacol. Biochem. Behav. 26:1987;801-812.
38. Serafin W.E. Drugs used in the treatment of asthma. Hardman J.G., Limbird L.E., Molinoff P.B., Ruddon R.W., Gilman A. The pharmacological basis of therapeutics. 9th ed:1996;659-682 McGraw Hill, New York.
39. Silverman K., Griffiths R.R. Low-dose caffeine discrimination and self-reported mood effects in normal volunteers. J. Exp. Anal. Behav. 57:1992;91-107.
40. Strohle A., Romeo E., Hermann B., Pasini A., Spalletta G., Di Michele F., Holsboer F., Rupprecht R. Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery. Biol. Psychiatry. 45:1999;274-277.
41. Uhde T.W. Caffeine provocation of panic. a focus on biological mechanisms Neurobiol. Panic Disorders. 14:1990;219-242.
42. Uzunov D.P., Cooper T.B., Costa E., Guidotti A. Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc. Natl. Acad. Sci. USA. 93:1996;12599-12604.
43. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. USA. 95:1998;3239-3244.
44. Wang M., Seippel L., Purdy R.H., Backstrom T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome. study on serum pregnenolone, pregnenolone sulfate, 5α-pregnane-3,20-dione and 3α-hydroxy-5α-pregnan-20-one J. Clin. Endocrinol. Metab. 81:1996;1076-1082.